Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleBasic Science Investigations

Variation of Specific Activities of 68Ga-Aquibeprin and 68Ga-Avebetrin Enables Selective PET Imaging of Different Expression Levels of Integrins α5β1 and αvβ3

Johannes Notni, Katja Steiger, Frauke Hoffmann, Dominik Reich, Markus Schwaiger, Horst Kessler and Hans-Jürgen Wester
Journal of Nuclear Medicine October 2016, 57 (10) 1618-1624; DOI: https://doi.org/10.2967/jnumed.116.173948
Johannes Notni
1Lehrstuhl für Pharmazeutische Radiochemie, Technische Universität München, Garching, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katja Steiger
2Institute of Pathology, Technische Universität München, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frauke Hoffmann
1Lehrstuhl für Pharmazeutische Radiochemie, Technische Universität München, Garching, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dominik Reich
1Lehrstuhl für Pharmazeutische Radiochemie, Technische Universität München, Garching, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus Schwaiger
3Department of Nuclear Medicine, Technische Universität München, Munich, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Horst Kessler
4Institute for Advanced Study and Center of Integrated Protein Science, Department Chemie, Technische Universität München, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hans-Jürgen Wester
1Lehrstuhl für Pharmazeutische Radiochemie, Technische Universität München, Garching, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 57 no. 10 1618-1624
DOI 
https://doi.org/10.2967/jnumed.116.173948
PubMed 
27151985

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication February 8, 2016
  • Accepted for publication March 29, 2016
  • Published online October 3, 2016.

Article Versions

  • previous version (May 5, 2016 - 12:17).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2016 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

  1. Johannes Notni1,
  2. Katja Steiger2,
  3. Frauke Hoffmann1,
  4. Dominik Reich1,
  5. Markus Schwaiger3,
  6. Horst Kessler4 and
  7. Hans-Jürgen Wester1
  1. 1Lehrstuhl für Pharmazeutische Radiochemie, Technische Universität München, Garching, Germany
  2. 2Institute of Pathology, Technische Universität München, Munich, Germany
  3. 3Department of Nuclear Medicine, Technische Universität München, Munich, Germany; and
  4. 4Institute for Advanced Study and Center of Integrated Protein Science, Department Chemie, Technische Universität München, Munich, Germany
  1. For correspondence or reprints contact: Johannes Notni, Lehrstuhl für Pharmazeutische Radiochemie, Technische Universität München, Walther-Meissner-Strasse 3, D-85748 Garching, Germany. E-mail: johannes.notni{at}tum.de
View Full Text

Statistics from Altmetric.com

Cited By...

  • 29 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Every step of the way: integrins in cancer progression and metastasis
    Hellyeh Hamidi, Johanna Ivaska
    Nature Reviews Cancer 2018 18 9
  • Exploring the Role of RGD-Recognizing Integrins in Cancer
    Markus Nieberler, Ute Reuning, Florian Reichart, Johannes Notni, Hans-Jürgen Wester, Markus Schwaiger, Michael Weinmüller, Andreas Räder, Katja Steiger, Horst Kessler
    Cancers 2017 9 9
  • In Vivo PET Imaging of the Cancer Integrin αvβ6 Using 68Ga-Labeled Cyclic RGD Nonapeptides
    Johannes Notni, Dominik Reich, Oleg V. Maltsev, Tobias G. Kapp, Katja Steiger, Frauke Hoffmann, Irene Esposito, Wilko Weichert, Horst Kessler, Hans-Jürgen Wester
    Journal of Nuclear Medicine 2017 58 4
  • Biological Relevance of RGD‐Integrin Subtype‐Specific Ligands in Cancer
    Saidu Sani, Mélissa Messe, Quentin Fuchs, Marina Pierrevelcin, Patrice Laquerriere, Natacha Entz‐Werle, Damien Reita, Nelly Etienne‐Selloum, Véronique Bruban, Laurence Choulier, Sophie Martin, Monique Dontenwill
    ChemBioChem 2021 22 7
  • Molar Activity of Ga-68 Labeled PSMA Inhibitor Conjugates Determines PET Imaging Results
    Alexander Wurzer, Julia Pollmann, Alexander Schmidt, Dominik Reich, Hans-Jürgen Wester, Johannes Notni
    Molecular Pharmaceutics 2018 15 9
  • PET and SPECT imaging of melanoma: the state of the art
    Weijun Wei, Emily B. Ehlerding, Xiaoli Lan, Quanyong Luo, Weibo Cai
    European Journal of Nuclear Medicine and Molecular Imaging 2018 45 1
  • There is a world beyond αvβ3-integrin: Multimeric ligands for imaging of the integrin subtypes αvβ6, αvβ8, αvβ3, and α5β1 by positron emission tomography
    Katja Steiger, Neil Gerard Quigley, Tanja Groll, Frauke Richter, Maximilian Alexander Zierke, Ambros Johannes Beer, Wilko Weichert, Markus Schwaiger, Susanne Kossatz, Johannes Notni
    EJNMMI Research 2021 11 1
  • Radiometal-labeled anti-VCAM-1 nanobodies as molecular tracers for atherosclerosis – impact of radiochemistry on pharmacokinetics
    Gezim Bala, Maxine Crauwels, Anneleen Blykers, Isabel Remory, Andrea L.J. Marschall, Stefan Dübel, Laurent Dumas, Alexis Broisat, Charlotte Martin, Steven Ballet, Bernard Cosyns, Vicky Caveliers, Nick Devoogdt, Catarina Xavier, Sophie Hernot
    Biological Chemistry 2019 400 3
  • Evaluation of agonist and antagonist radioligands for somatostatin receptor imaging of breast cancer using positron emission tomography
    Iulia Dude, Zhengxing Zhang, Julie Rousseau, Navjit Hundal-Jabal, Nadine Colpo, Helen Merkens, Kuo-Shyan Lin, François Bénard
    EJNMMI Radiopharmacy and Chemistry 2017 2 1
  • N-Methylation of isoDGR Peptides: Discovery of a Selective α5β1-Integrin Ligand as a Potent Tumor Imaging Agent
    Tobias G. Kapp, Francesco Saverio Di Leva, Johannes Notni, Andreas F. B. Räder, Maximilian Fottner, Florian Reichart, Dominik Reich, Alexander Wurzer, Katja Steiger, Ettore Novellino, Udaya Kiran Marelli, Hans-Jürgen Wester, Luciana Marinelli, Horst Kessler
    Journal of Medicinal Chemistry 2018 61 6

Article usage

Article usage: May 2016 to April 2025

AbstractFullPdf
May 2016462055
Jun 201615107
Jul 2016113014
Aug 201681012
Sep 201691019
Oct 20166301150
Nov 2016213631
Dec 20168638
Jan 2017116619
Feb 20174118
Mar 201777513
Apr 201736411
May 201754814
Jun 201724127
Jul 2017361010
Aug 2017361113
Sep 201729412
Oct 20172675
Nov 201733610
Dec 20172048
Jan 201835812
Feb 20182576
Mar 201834129
Apr 20182458
May 2018361015
Jun 20181726
Jul 20181445
Aug 20181542
Sep 20181536
Oct 2018281813
Nov 20188124
Dec 20181789
Jan 201924129
Feb 201912135
Mar 20192178
Apr 201922811
May 20192159
Jun 20191859
Jul 20192468
Aug 20193256
Sep 201918811
Oct 20191988
Nov 201926719
Dec 201922146
Jan 20202866
Feb 20201336
Mar 202019710
Apr 20202248
May 202023311
Jun 202026610
Jul 20201748
Aug 2020811
Sep 20202485
Oct 20201625
Nov 20201269
Dec 20202133
Jan 202115107
Feb 2021132223
Mar 202115147
Apr 2021789
May 202113111
Jun 20218146
Jul 202141015
Aug 20214106
Sep 2021666
Oct 202171117
Nov 2021161018
Dec 20218156
Jan 20227288
Feb 20229105
Mar 20226238
Apr 20225229
May 202261615
Jun 2022101311
Jul 20223157
Aug 20225137
Sep 202271410
Oct 2022121210
Nov 2022365
Dec 20224121
Jan 202323618
Feb 20233162
Mar 202362312
Apr 20232197
May 20232169
Jun 202322011
Jul 202321614
Aug 202331311
Sep 20233226
Oct 20232717
Nov 2023131398
Dec 202332311
Jan 20248319
Feb 202472511
Mar 202411429
Apr 202462316
May 202463014
Jun 20249245
Jul 202463224
Aug 2024113337
Sep 2024102826
Oct 20246256
Nov 2024191916
Dec 202493213
Jan 202512226
Feb 202585814
Mar 20251218925
Apr 2025133725
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 57 (10)
Journal of Nuclear Medicine
Vol. 57, Issue 10
October 1, 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Variation of Specific Activities of 68Ga-Aquibeprin and 68Ga-Avebetrin Enables Selective PET Imaging of Different Expression Levels of Integrins α5β1 and αvβ3
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Variation of Specific Activities of 68Ga-Aquibeprin and 68Ga-Avebetrin Enables Selective PET Imaging of Different Expression Levels of Integrins α5β1 and αvβ3
Johannes Notni, Katja Steiger, Frauke Hoffmann, Dominik Reich, Markus Schwaiger, Horst Kessler, Hans-Jürgen Wester
Journal of Nuclear Medicine Oct 2016, 57 (10) 1618-1624; DOI: 10.2967/jnumed.116.173948

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Variation of Specific Activities of 68Ga-Aquibeprin and 68Ga-Avebetrin Enables Selective PET Imaging of Different Expression Levels of Integrins α5β1 and αvβ3
Johannes Notni, Katja Steiger, Frauke Hoffmann, Dominik Reich, Markus Schwaiger, Horst Kessler, Hans-Jürgen Wester
Journal of Nuclear Medicine Oct 2016, 57 (10) 1618-1624; DOI: 10.2967/jnumed.116.173948
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Increasing molar activity by HPLC purification improves 68Ga-DOTA-NAPamide tumor accumulation in a B16/F1 melanoma xenograft model
  • Targeting Cardiovascular Implant Infection: Multimodality and Molecular Imaging
  • In Vivo PET Imaging of the Cancer Integrin {alpha}v{beta}6 Using 68Ga-Labeled Cyclic RGD Nonapeptides
  • Google Scholar

More in this TOC Section

  • Tumor Uptake of Anti-CD20 Fabs Depends on Tumor Perfusion
  • How Sensitive Is the Upper Gastrointestinal Tract to 90Y Radioembolization? A Histologic and Dosimetric Analysis in a Porcine Model
  • 11C-Methionine PET of Myocardial Inflammation in a Rat Model of Experimental Autoimmune Myocarditis
Show more Basic Science Investigations

Similar Articles

Keywords

  • Positron Emission Tomography
  • receptor density
  • 68Ga
  • Preclinical Imaging
SNMMI

© 2025 SNMMI

Powered by HighWire